Position in OMER
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,604,812
+$390,412 QoQ
Shares Held
168,750
+46.7% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#28
of 169 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $3,859,296 across 14 Biotechnology names. OMER ranks #1 (41.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OMER |
Omeros Corp
This page
|
168,750 | $1,604,812 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
56,723 | $847,441 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,127 | $559,814 | |
| 4 | ANAB |
Anaptysbio, Inc
|
5,000 | $337,500 | |
| 5 | GLSI |
Greenwich LifeSciences, Inc.
|
10,740 | $251,960 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,215 | $175,627 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
2,500 | $44,925 | |
| 8 | INSM |
INSMED Inc
|
200 | $21,324 |
All Filings in OMER
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,604,812 | 168,750 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,214,400 | 115,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,017,915 | 59,250 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $12,300 | 3,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,400 | 5,800 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $47,676 | 5,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $847,704 | 85,800 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $29,973 | 7,550 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,833 | 10,550 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $408,941 | 118,534 | Shares | Other | 2024-05-16 | |
| 2023-12-31 | $533,084 | 163,023 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $613,267 | 210,023 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $927,781 | 170,548 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $1,085,853 | 233,517 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $732,277 | 324,017 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $459,024 | 145,722 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $773,305 | 281,202 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $669,885 | 111,462 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $937,410 | 145,787 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,853,017 | 134,374 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,994,110 | 134,374 | Shares | Other | 2021-11-12 | |
| 2020-12-31 | $476,285 | 33,330 | Shares | Other | 2021-11-12 | |
| 2020-09-30 | $336,996 | 33,333 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||